Safety and efficacy of alfuzosin 10 mg once-daily in the treatment of lower urinary tract symptoms and clinical benign prostatic hyperplasia: A pooled analysis of three double-blind, placebo-controlled studies

Claus Roehrborn, P. Van Kerrebroeck, J. Nordling

Research output: Contribution to journalArticlepeer-review

144 Scopus citations

Fingerprint Dive into the research topics of 'Safety and efficacy of alfuzosin 10 mg once-daily in the treatment of lower urinary tract symptoms and clinical benign prostatic hyperplasia: A pooled analysis of three double-blind, placebo-controlled studies'. Together they form a unique fingerprint.

Medicine & Life Sciences